ArticleBMC research notes2026
Callosal glia, GABAergic interneurons, and apoptotic profiles in the brains of cypermethrin-exposed male and female rats.
Article in BMC research notes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveCypermethrin's effects on the corpus callosum, the brain's largest white matter tract essential for interhemispheric communication, remain unexplored, particularly regarding sex‑dependent vulnerability. We examined the effects of sub‑chronic cypermethrin exposure (6.25 and 12.5 mg/kg) on corpus callosum integrity in male and female Wistar rats, focusing on glial populations, GABAergic interneurons, and apoptosis, using biochemical (brain‑derived neurotrophic factor [BDNF] and total protein) and immunohistochemical markers (GFAP, IBA‑1, parvalbumin, cleaved caspase‑3).
resultsCypermethrin caused sex‑dependent behavioral changes: males showed increased rearing frequency while females showed decreased rearing. BDNF concentrations significantly decreased in low‑dose males (p = 0.0079) and females (p = 0.0039), with partial recovery in high‑dose females. GFAP‑positive astrocyte density decreased in exposed males but increased in low‑dose females (p = 0.024). IBA‑1‑positive microglia decreased significantly in both sexes, particularly in low‑dose groups (males: p = 0.0001; females: p = 0.0075). Parvalbumin‑positive GABAergic interneuron density decreased in low‑dose males (p = 0.029) and both female groups. Cleaved caspase‑3 expression increased in all treated groups, with high‑dose males most affected (p < 0.0001). H&E staining revealed dose‑dependent cellular density reductions, greatest in high‑dose males (p = 0.0001). Collectively, cypermethrin induced sex‑dependent white matter neurotoxicity, with males showing greater susceptibility than females.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.